Weight loss drugs are bringing down the country's obesity rate, a survey shows
Summary
More people in the United States are using injectable drugs like Wegovy and Zepbound to help with weight loss. This increase in usage has contributed to a slight decrease in the country's obesity rate, as found in a Gallup survey.Key Facts
- The obesity rate in the U.S. dropped to 37% from 39.9% over the past three years.
- Usage of weight loss drugs, such as semaglutide and tirzepatide, has more than doubled in a year and a half.
- 12.4% of surveyed Americans now use these drugs, up from 5.8% in early 2024.
- GLP-1 agonists, like semaglutide, suppress hunger and slow digestion.
- These drugs were first available in the U.S. in 2021.
- Obesity rates fell most among people aged 40 to 64, with higher drug usage in this group.
- Women are using these drugs more than men, leading to more weight loss in women.
- Insurance coverage for these drugs is reducing, which could make them cost $500 monthly out of pocket.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.